Sirolimus Monotherapy in the Treatment of Antiphospholipid Antibody Related Thrombocytopenia

Clinical trial NCT06722586 · RECRUITING

Trial details

NCT number: NCT06722586
Sponsor: Peking University First Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Antiphospholipid (aPL)-Positive Thrombocytopaenia

Start date: 2025-01-07
Primary completion: 2027-12-01
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.